MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction

Multiple Sclerosis

Volumn 15, Issue 7, 2009, Pages 811-817

  Anderson, Valerie M ^a   Fisniku, L K ^a   Altmann, D R ^a,b   Thompson, A J ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Atrophy; Cerebellum; Gray matter; Multiple sclerosis; Region of interest

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBELLUM INJURY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER;

ADULT; ATROPHY; CASE-CONTROL STUDIES; CEREBELLAR CORTEX; CEREBELLUM; CROSS-SECTIONAL STUDIES; DEMYELINATING DISEASES; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 67649365980     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508101934     Document Type: Article

References (46)

1. Bo, L, Vedeler, CA, Nyland, HI, Trapp, BD, Mork, SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62: 723-732.
2. Peterson, JW, Bo, L, Mork, S, Chang, A, Trapp, BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
3. Kutzelnigg, A, Lucchinetti, CF, Stadelmann, C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712.
4. Geurts, JJ, Pouwels, PJ, Uitdehaag, BM, Polman, CH, Barkhof, F, Castelijns, JA. Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversionrecovery MR imaging. Radiology 2005; 236: 254-260.
5. Bagnato, F, Butman, JA, Gupta, S, et al. In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol 2006; 27: 2161-2167.
6. Nelson, F, Poonawalla, AH, Hou, P, Huang, F, Wolinsky, JS, Narayana, PA. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 1645-1649.
7. Calabrese, M, De Stefano, N, Atzori, M, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007; 64: 1416-1422.
8. Sastre-Garriga, J, Ingle, GT, Chard, DT, et al. Grey and white matter volume changes in early primary progressive multiple sclerosis: A longitudinal study. Brain 2005; 128: 1454-1460.
9. Tiberio, M, Chard, DT, Altmann, DR, et al. Gray and white matter volume changes in early RRMS: A 2-year longitudinal study. Neurology 2005; 64: 1001-1007.
10. Valsasina, P, Benedetti, B, Rovaris, M, Sormani, MP, Comi, G, Filippi, M. Evidence for progressive gray matter loss in patients with relapsing-remitting MS. Neurology 2005; 65: 1126-1128.
11. Zivadinov, R, Locatelli, L, Cookfair, D, et al. Interferon beta-1a slows progression of brain atrophy in relapsingremitting multiple sclerosis predominantly by reducing gray matter atrophy. Mult Scler 2007; 13: 490-501.
12. Dalton, CM, Chard, DT, Davies, GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101-1107.
13. Fisniku, LK, Chard, DT, Jackson, JS, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64: 247-254.
14. Sanfilipo, MP, Benedict, RH, Sharma, J, Weinstock-Guttman, B, Bakshi, R. The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction. Neuroimage 2005; 26: 1068-1077.
15. Mesaros, S, Rovaris, M, Pagani, E, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008; 65: 1223-1230.
16. Prinster, A, Quarantelli, M, Orefice, G, et al. Grey matter loss in relapsing-remitting multiple sclerosis: A voxelbased morphometry study. Neuroimage 2006; 29: 859-867.
17. Morgen, K, Sammer, G, Courtney, SM, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 2006; 30: 891-898.
18. Audoin, B, Davies, GR, Finisku, L, Chard, DT, Thompson, AJ, Miller, DH. Localization of grey matter atrophy in early RRMS: A longitudinal study. J Neurol 2006; 253: 1495-1501.
19. Sepulcre, J, Sastre-Garriga, J, Cercignani, M, Ingle, GT, Miller, DH, Thompson, AJ. Regional gray matter atrophy in early primary progressive multiple sclerosis: A voxelbased morphometry study. Arch Neurol 2006; 63: 1175-1180.
20. Henry, RG, Shieh, M, Okuda, DT, Evangelista, A, Gorno-Tempini, ML, Pelletier, D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008; 79: 1236-1244.
21. Bermel, RA, Innus, MD, Tjoa, CW, Bakshi, R. Selective caudate atrophy in multiple sclerosis: A 3D MRI parcellation study. Neuroreport 2003; 14: 335-339.
22. Cifelli, A, Arridge, M, Jezzard, P, Esiri, MM, Palace, J, Matthews, PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002; 52: 650-653.
23. Wylezinska, M, Cifelli, A, Jezzard, P, Palace, J, Alecci, M, Matthews, PM. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003; 60: 1949-1954.
24. Kutzelnigg, A, Faber-Rod, JC, Bauer, J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007; 17: 38-44.
25. Ceccarelli, A, Rocca, MA, Pagani, E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008; 42: 315-322.
26. Amato, MP, Ponziani, G. A prospective study on the prognosis of multiple sclerosis. Neurol Sci 2000; 21: S831-S838.
27. Poser, CM, Paty, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
28. Lublin, FD, Reingold, SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
29. Ashburner, J, Friston, KJ. Unified segmentation. Neuroimage 2005; 26: 839-851.
30. Plummer, DL. DispImage: A display and analysis tool for medical images. Revista di Neuroradiologia 1992; 5: 489-495.
31. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
32. Cutter, GR, Baier, ML, Rudick, RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-882.
33. Altman, DG. Practical statistics for medical research. 1991 Chapman & Hall.
34. Edwards, SG, Gong, QY, Liu, C, et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 1999; 122: 291-301.
35. Liu, C, Edwards, S, Gong, Q, Roberts, N, Blumhardt, LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999; 66: 323-330.
36. Filippi, M, Mastronardo, G, Rocca, MA, Pereira, C, Comi, G. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 1998; 158: 148-153.
37. Lin, X, Blumhardt, LD, Constantinescu, CS. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: A threedimensional MRI study. Acta Neurol Scand 2003; 108: 401-406.
38. Li, Y, Chiaravalloti, ND, Hillary, FG, et al. Differential cerebellar activation on functional magnetic resonance imaging during working memory performance in persons with multiple sclerosis. Arch Phys Med Rehabil 2004; 85: 635-639.
39. Rocca, MA, Valsasina, P, Ceccarelli, A, et al. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp 2009; 30: 276-290.
40. Davie, CA, Barker, GJ, Webb, S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 118: 1583-1592.
41. Brenneis, C, Boesch, SM, Egger, KE, et al. Cortical atrophy in the cerebellar variant of multiple system atrophy: A voxel-based morphometry study. Mov Disord 2006; 21: 159-165.
42. Ginestroni, A, Della, NR, Tessa, C, et al. Brain structural damage in spinocerebellar ataxia type 1: A VBM study. J Neurol 2008; 255: 1153-1158.
43. Lukas, C, Schols, L, Bellenberg, B, et al. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: A voxel-based morphometry study. Neurosci Lett 2006; 408: 230-235.
44. Gilmore, CP, Donaldson, I, Bo, L, Owens, T, Lowe, JS, Evangelou, N. Regional variations in the extent and pattern of grey matter demyelination in Multiple Sclerosis: A comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009; 80: 182-187.
45. Tjoa, CW, Benedict, RH, Weinstock-Guttman, B, Fabiano, AJ, Bakshi, R. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005; 234: 17-24.
46. Fisniku, LK, Brex, PA, Altmann, DR, et al. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808-817.